Facilitated By

San Antonio Medical Foundation

News

  • Biothera unveils updated data from Phase 2 mTNBC trial at SABCS

    Biothera Pharmaceuticals is a renowned biotechnology company ... -triple-negative-breast-cancer-patients-at-san-antonio-breast-cancer-symposium/.

  • Global Medical Equipment Calibration Service Market, Top key players are Biomed Technologies ...

    Top key players are @ Biomed Technologies, NS Medical Systems, JPen Medical, Tektronix, Fluke Biomedical, JM Test ... 1604 W San Antonio,.

  • SABCS: Foundation's blood test predicts early relapses in triple-negative breast cancer

    The ongoing study, presented at the San Antonio Breast Cancer Symposium, enrolled 196 women and sequenced circulating tumor DNA in 142 ...

  • Cellectar Presents Poster at the American Association for Cancer Research (AACR) San Antonio ...

    13, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (CLRB), ... a poster at the AACR San Antonio Breast Cancer Symposium in San Antonio, ...

  • BriaCell Announces Clinical Data as Presented at the 2019 San Antonio Breast Cancer Symposium®

    (“BriaCell” or the “Company”) (TSXV:BCT, OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapies for ...